[ Wed, Oct 13th 2021 ]: WOPRAI
[ Wed, Oct 13th 2021 ]: WOPRAI
[ Wed, Oct 13th 2021 ]: WOPRAI
[ Wed, Oct 13th 2021 ]: WOPRAI
[ Wed, Oct 13th 2021 ]: WOPRAI
[ Wed, Oct 13th 2021 ]: WOPRAI
[ Wed, Oct 13th 2021 ]: WOPRAI
[ Wed, Oct 13th 2021 ]: WOPRAI
[ Wed, Oct 13th 2021 ]: WOPRAI
[ Wed, Oct 13th 2021 ]: WOPRAI
[ Wed, Oct 13th 2021 ]: WOPRAI
[ Wed, Oct 13th 2021 ]: WOPRAI
[ Wed, Oct 13th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Tue, Oct 12th 2021 ]: WOPRAI
[ Mon, Oct 11th 2021 ]: WOPRAI
[ Mon, Oct 11th 2021 ]: WOPRAI
[ Mon, Oct 11th 2021 ]: WOPRAI
[ Mon, Oct 11th 2021 ]: WOPRAI
[ Mon, Oct 11th 2021 ]: WOPRAI
[ Mon, Oct 11th 2021 ]: WOPRAI
[ Mon, Oct 11th 2021 ]: WOPRAI
[ Mon, Oct 11th 2021 ]: WOPRAI
[ Mon, Oct 11th 2021 ]: WOPRAI
[ Mon, Oct 11th 2021 ]: WOPRAI
[ Mon, Oct 11th 2021 ]: WOPRAI
[ Mon, Oct 11th 2021 ]: WOPRAI
[ Mon, Oct 11th 2021 ]: WOPRAI
David Lebowitz Maintained (SNDX) at Hold with Increased Target to $21 on, Oct 12th, 2021
🞛 This publication is a summary or evaluation of another publication
David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Hold with Increased Target from $20 to $21 on, Oct 12th, 2021.
David, nor any peers, have made any analyst calls on SNDX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30